{"as_of":"2026-08-06T09:32:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:32c6183a87976312a9a06ef6d6c1b34a89fa0d912a87d83c364de57faa09cebb","coverage":[{"denominator":44,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":44,"source":"paper_references, paper_reference_links","source_observed_at":"2026-05-08T17:20:32.422258Z","state":"measured"},{"denominator":44,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":44,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-06T06:34:29.942622+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2605.04212/citation-record","integrity":"/paper/2605.04212/integrity","json":"/paper/2605.04212/citation-record.json","paper":"/paper/2605.04212"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"The Annals of Statistics , volume=","venue":null,"work_id":"58905d74-fd41-4ae4-8564-a554c446ea83","year":1982},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:a41554cbd6cb2bb592efe2599c6b724bb3ff550f67eabad1a33489120dc10348","observation_id":"ecbb926e-5bed-47a7-8dad-94f03453eeef","resolution":{"observed_at":"2026-05-26T08:06:56.657051Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-07-06T04:51:56.861010Z","title":"Biometrics , volume=","venue":null,"work_id":"be3d4a86-0984-43a0-bd41-a229c8705c70","year":2014},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:3d397c416cde4bf0f4890a5309496eddbda235c9663d6029bb1e586477b48e6f","observation_id":"9ce900b2-fde9-4bc9-9e18-b071dcf35752","resolution":{"observed_at":"2026-05-26T08:06:56.673712Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , volume=","venue":null,"work_id":"9773b2cb-79b4-4836-bed3-272ed92de404","year":2023},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:4ebbf42cf8232e747e89dbcc4f19909101e3a98bdbc24c8cf50856c942bbeef5","observation_id":"2f006450-19e8-4257-89ab-b5beb34f5110","resolution":{"observed_at":"2026-05-26T08:06:56.694079Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistical Methods in Medical Research , volume=","venue":null,"work_id":"a611bc43-ca41-46ec-8fb2-69af49fb3e45","year":2024},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:d23b3ddf211c08ed4569d7a6a9df387c52898bef17204edfea8e110e787cd44b","observation_id":"cddecb38-41ae-4312-b463-783b295e9b9e","resolution":{"observed_at":"2026-05-26T08:06:56.670819Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistical Methods in Medical Research , volume=","venue":null,"work_id":"745f529b-56a8-49dc-a0ad-56b5647ebf9d","year":2024},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:2eba40fdd7bf4ad2fd821dc7dd52bf43b4752eaacf84492c1ee2108eab15db00","observation_id":"de0ff383-e139-43ff-8f1d-c4d9a7d29f8d","resolution":{"observed_at":"2026-05-26T08:06:56.664729Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistical methods in medical research , volume=","venue":null,"work_id":"3f4812f8-eea2-4857-bfec-6ef50c0992a2","year":2017},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:563344b0050bdc93113a0120514dfe2351a12762df5e4c08e6faed503f7e3fb3","observation_id":"f75459d1-1ca9-47df-9fa0-75a5dc9f9976","resolution":{"observed_at":"2026-05-26T08:06:56.647962Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Cancer Chemotherapy and Pharmacology , volume=","venue":null,"work_id":"4ed0f759-91f9-478c-b095-2b5e14502084","year":2011},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:d6b871473f303cd30e78d2e3e81ad56438cfaef67791dd2cc26e048f71c18d68","observation_id":"ad4cd1e8-15f0-40d9-9d7a-aa977465459a","resolution":{"observed_at":"2026-05-26T08:06:56.620460Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Contemporary Clinical Trials , volume=","venue":null,"work_id":"152c71c0-08d8-480d-b1d3-dc455e3ec475","year":2020},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:2ec228e40de24271a049523ffa0b6dc7d208402782c8914aac3214f87861192f","observation_id":"a8d47222-701e-409b-adef-0821d8a67052","resolution":{"observed_at":"2026-05-26T08:06:56.602394Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistical methods in medical research , volume=","venue":null,"work_id":"78c07c44-6bd3-4293-84ae-02504d6a2f17","year":2020},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:58dd8198655f44a2722c6b91ed59c1cdbd757b695d32151d48f0eb3e606e47bd","observation_id":"2cebd643-d8a3-40aa-86ef-3b8ab01c13d7","resolution":{"observed_at":"2026-05-26T08:06:56.617478Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistics in medicine , volume=","venue":null,"work_id":"a3556837-c5ce-4603-a379-fa62e0a6247c","year":2015},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:addef91e17d55acc1131e5f32a967f847295ecbb49a6c11f6b1149aaa33e5acf","observation_id":"87602afa-4243-4f84-b243-b4e2d5cf5d31","resolution":{"observed_at":"2026-05-26T08:06:56.653994Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistics in medicine , volume=","venue":null,"work_id":"6e5b6515-409e-4b60-818d-d6b41760e5e2","year":2016},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:6e9b2cdc50c8a66abe37472c335f4df266b858bcdaf279ec6541fc14f940c949","observation_id":"d71a2188-32db-4ec9-9cb3-1ba0fb2773fc","resolution":{"observed_at":"2026-05-26T08:06:56.687327Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biostatistics , volume=","venue":null,"work_id":"6756092e-869f-4461-a2b7-953a050ff05b","year":2022},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:e81b2bf8e0f3434605e3588220513262ad0bca66ab618bd1482a3327b7485db1","observation_id":"3ec7265b-f931-43ef-b2e7-820546ae951b","resolution":{"observed_at":"2026-05-26T08:06:56.626869Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistical methods in drug combination studies , volume=","venue":null,"work_id":"b6b83734-c600-45ab-91a8-2e2957a86c86","year":2015},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:989b17e1abc2adb04ef0e75c441990459938a6a89061ae616fc2d6ad33d3482d","observation_id":"c1accc04-b364-4bdb-abf8-beeeaf8431d0","resolution":{"observed_at":"2026-05-26T08:06:56.579854Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistics in medicine , volume=","venue":null,"work_id":"4bd1644d-50f1-4b53-b36f-88d015d7fd05","year":2008},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:6f3f58ed67c48c4265615f634e336ef217c9e31b3911d81bbaf3fb09e571a401","observation_id":"90e3a42d-c923-458d-83d4-9474c54fe890","resolution":{"observed_at":"2026-05-26T08:06:56.576674Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , volume=","venue":null,"work_id":"098f8abb-9741-4f00-bacf-2a1b770a40e7","year":2003},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:43a49568c894f228c869d78e626b388cf8f9443405f0ca4b6d71764d8028aec9","observation_id":"b9e02b47-158b-4f7f-acc0-c2f8456b1e0f","resolution":{"observed_at":"2026-05-26T08:06:56.623355Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , volume=","venue":null,"work_id":"3837aa28-7cee-4202-b988-119200ff0680","year":2011},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:b57a7db5b71b0d975983d5727300d6a83531a8d343cd899bcf89aa3b1b65916a","observation_id":"51fada20-f0d1-485f-a425-4adbeee520d4","resolution":{"observed_at":"2026-05-26T08:06:56.635543Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Pharmaceutical statistics , volume=","venue":null,"work_id":"7542da35-0f10-48e0-9b04-8a4c947ca9fc","year":2014},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:a6dfc1cee9bfe9e677050f3bc168f6b8495d9bf01885639bfff9e54a0adf49c7","observation_id":"31a37dd8-d265-48bb-8900-a39855df8b69","resolution":{"observed_at":"2026-05-26T08:06:56.696890Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Journal of the Royal Statistical Society Series C: Applied Statistics , volume=","venue":null,"work_id":"01fd9599-3b70-4973-a258-aa6a65f48c2b","year":2009},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:3e45915353e7abf9183399194339fc1d7a34cdc9135111c8df6fbe3622c5f512","observation_id":"692e6408-9f3d-4561-86b6-9fa05b4ab2f1","resolution":{"observed_at":"2026-05-26T08:06:56.595494Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , volume=","venue":null,"work_id":"e0d55b10-9c5c-4325-9355-2eecf77a45ce","year":2010},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:56b653ab9d62bd52d322e0fcd2f2a91c622639c4e08ba14652ceff6ca9b980ee","observation_id":"00880a78-e3c2-4619-bbdf-8436c676aa8a","resolution":{"observed_at":"2026-05-26T08:06:56.681274Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistics in medicine , volume=","venue":null,"work_id":"5d21103a-1469-46ca-98da-02c7a6033d04","year":2008},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":20,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:1962d77425546045c85ecc058d5bfb01e9b610fe9405f03a16af72f4139bbb83","observation_id":"64a3316a-5104-442c-91d1-d11ae46fa055","resolution":{"observed_at":"2026-05-26T08:06:56.573572Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Annals of Oncology , volume=","venue":null,"work_id":"4d086034-8532-44f9-8bcd-6ac01359cadc","year":2015},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":21,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:b54ab4eb4799abca0836721a88ec50e6acad5c77afa3641d40760337eed74b0e","observation_id":"4b1096f8-4f62-4efb-9e51-c7eda75cf755","resolution":{"observed_at":"2026-05-26T08:06:56.678694Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , pages=","venue":null,"work_id":"cdab3f00-fccd-44d5-9fff-b14caa2f5fe8","year":1990},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":22,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:5816a4f3756af5bd59514a2c2a0c8dfdafc879a3ad321da4b8d8f17b50e4f78a","observation_id":"b58f95bf-5367-44b0-a838-4b3af3990dfd","resolution":{"observed_at":"2026-05-26T08:06:56.614491Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Statistics in Cancer Drug Development , publisher =","venue":null,"work_id":"5fb675e6-9e07-4157-beb9-e22ec50a3b7e","year":2025},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:524bb46e45983d35b9bb93021bfca4b15d95515342a9047ba7d4c5417e205325","observation_id":"073c6f57-1119-4d09-b56a-d2b95ddc05c9","resolution":{"observed_at":"2026-05-26T08:06:56.650999Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Pepe, M","venue":null,"work_id":"5779ff6f-59fd-4e78-a156-3bf51a419946","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":24,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:5d3367b8c43149e959ecd6f30e926164b37f6bdf5d963260ad3c5d4293125339","observation_id":"a5ca7d5c-b363-436a-888d-94596d13153c","resolution":{"observed_at":"2026-05-26T08:06:56.611674Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Contemporary Clinical Trials , year =","venue":null,"work_id":"527e808b-88a8-43fa-bc26-0f1019df2451","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":25,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:603643501389c5f7401296b921ca3c70aa0aaaf23ac2306b0c322b2de1c61864","observation_id":"b989c3c9-44f4-4c3b-b7a1-6b2d2c301af4","resolution":{"observed_at":"2026-05-26T08:06:56.638764Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Yuan, Y","venue":null,"work_id":"5444212b-15f7-4588-b76f-aa3c78f28d3c","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":26,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:c2db61635f85dc25902cf20949b45ab3b727df516ca94f0a4ba4cc6bcfac5c3f","observation_id":"34d67349-326d-4557-9b9f-469293a949f5","resolution":{"observed_at":"2026-05-26T08:06:56.586415Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Rogatko, A","venue":null,"work_id":"294327f3-226e-4bd7-b66b-5b90a7e3cf93","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":27,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:98401766c91b19cd8512aa3c426cbf99e02e3d045156e134ee4929c49b1a53e0","observation_id":"3ce2be07-b0e7-4281-a488-0271a2ef7a2f","resolution":{"observed_at":"2026-05-26T08:06:56.598762Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":null,"venue":null,"work_id":"9c1f7b22-8a88-4d72-9bf4-f9534a34c3de","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":28,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:819636e930a7675d673ad91054b4c5b33d01ebb0819a14eeebe49025ff1471ad","observation_id":"1e596c08-2cce-4f25-886a-9039bf28baae","resolution":{"observed_at":"2026-05-26T08:06:56.583139Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1111/cts.12582","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"and Swift, B","venue":"Clinical and Translational Science","work_id":"8f69e272-999a-4e90-b862-5ad5b314706f","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":29,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:9258eae0d58a8581d8a55601fc795efdf94659046171b7fdb4ee6d63d0a00d1c","observation_id":"13fcb94c-c156-4cda-8577-0504f857962c","resolution":{"observed_at":"2026-05-08T17:23:40.907050Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Dubois, F","venue":null,"work_id":"f7aa6dd2-1e8e-4f8e-a50e-03f47cc0dd63","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":30,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:3fc48c2143900ec17d2ad689598416e315b3c70d864a0522db4e63d6bb5195da","observation_id":"98de8c14-1fed-443e-9901-5419a2351f60","resolution":{"observed_at":"2026-05-26T08:06:56.632581Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Wang, K","venue":null,"work_id":"27b8a07d-0bda-4e46-96f6-ed640c9ff29d","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":31,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:f71a01347c5384e202b9080872f03349a2c1b60fde93e4af1ee496a20652f46a","observation_id":"6a2004a4-ef4f-4363-b0d9-a2d3269a4813","resolution":{"observed_at":"2026-05-26T08:06:56.609146Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Biometrics , volume=","venue":null,"work_id":"ccb4371b-5654-4eca-b9b6-cbd6be2a602a","year":2005},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":32,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:7a503b1e52655cf0b64a5fd3cbe1115a1954c6f2dc1cc402f35635a6410381dd","observation_id":"54e35012-fc95-483b-939c-05cb17c970cb","resolution":{"observed_at":"2026-05-26T08:06:56.589631Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Cui, Y","venue":null,"work_id":"acbd4acc-38ab-477e-b9dd-a06bb551e5ec","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":33,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:a10660a2effcba8ace97493222ef6a8dbff005ec57d92d7471e137abb1692877","observation_id":"c7be1766-f4c2-4241-aafb-f23a3d647e54","resolution":{"observed_at":"2026-05-26T08:06:56.645032Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Qin, R","venue":null,"work_id":"5a19951b-895a-4079-b7b0-62762f4cb9b5","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":34,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:56f07a71737f3cb815c132dff19e20fb2ede8720a8ab7c1fb1f610ae5126b3c8","observation_id":"6fe0fcf8-3ae2-4144-8cc5-d7acfaa443a2","resolution":{"observed_at":"2026-05-26T08:06:56.629782Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"Journal of Biopharmaceutical Statistics , volume=","venue":null,"work_id":"7dc700c3-1357-4fcc-8503-4a5fd3ff310e","year":2009},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":35,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:2ab25d09ec9df92378ae3efb7b58cad537ed3b17dae77d62a0c19b7fd1e45c54","observation_id":"78d318a3-1489-4e44-b88f-9b8cf77ad8cf","resolution":{"observed_at":"2026-05-26T08:06:56.592454Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Yuan, Y","venue":null,"work_id":"0ec9199c-a2bb-4ce3-ab47-99cc52158977","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":36,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:f12e2e9c0e70251c4b4638884de3ee55a27c9e78a47ea871b9fdb607ba94c27c","observation_id":"95ecf593-7787-4677-b729-38054eaa50cc","resolution":{"observed_at":"2026-05-26T08:06:56.641746Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Neuenschwander, B","venue":null,"work_id":"7d4d8085-47d5-423e-a376-411e57ab9376","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":37,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:1828662813e9cdbb59f8f768ccd007e44be8c7708845a01001ecb46e8d5475ca","observation_id":"c08e3195-736a-4919-9c0f-6457c0b97320","resolution":{"observed_at":"2026-05-26T08:06:56.690303Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Conaway, M","venue":null,"work_id":"3107abc8-4f4c-40b3-9a24-bbefcfd28696","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":38,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:ad9a47a7ab3ca61dce0c405e88f69e443feaf2baf70e8a5f0db70bc5ddd5c37e","observation_id":"5b04f2ba-38d2-4e1b-b89b-db4f82d678e2","resolution":{"observed_at":"2026-05-26T08:06:56.684222Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Lebecq, A","venue":null,"work_id":"b0d22970-af98-4d6d-9a59-9eb10ac5b6db","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":39,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:485bd9b358e87955169c61326e0f92e4698effc57dea267249db3a8ca2122fd9","observation_id":"f8fa4052-6350-40b9-918d-ee4e888f42e1","resolution":{"observed_at":"2026-05-26T08:06:56.676280Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Millikan, R","venue":null,"work_id":"2f0480e7-e3d3-45b8-8b89-bfdc5b6bec21","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":40,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:d1a378da0e416bbb2a188a87a705f67ce67848e8f430159aa4e55c73f3b39e16","observation_id":"7acef5e5-4311-4956-ae0a-2481306f766f","resolution":{"observed_at":"2026-05-26T08:06:56.605760Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Capkun-Niggli, G","venue":null,"work_id":"e92da131-ec98-4d65-9783-c82575d0a8b8","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":41,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:cb2b0a1059bd2c3d8e081c06eb523351e71f9ec2eba496f118bf60f72767800a","observation_id":"c9c560d6-5657-490d-a434-eb4643f23e38","resolution":{"observed_at":"2026-05-26T08:06:56.667736Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"and Zhou, H","venue":null,"work_id":"ad13a030-603a-44f5-98e7-c5120c01f39a","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":42,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:b4331cdcc6a90885cf2ca1aad472bdd4bca2edd970ac7e3dd0c452c5e3819366","observation_id":"1ed9f05d-8cad-4d64-8fb2-2abfcb6b6b28","resolution":{"observed_at":"2026-05-26T08:06:56.659910Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1177/1740774510382799","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"Clinical Trials , year =","venue":"Clinical Trials","work_id":"48f27d59-ba7f-4051-b136-b192b3f28c84","year":null},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":43,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:cf169320ad20339e476959e433c1967af1bac3e36acf1765f971fda04c4586f7","observation_id":"6390bffb-f3a3-41e3-ac89-493500523baa","resolution":{"observed_at":"2026-05-08T17:23:40.910585Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1016/j.conctc.2022.100943","metadata_source":"arxiv_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"and Lin, R","venue":"Contemporary Clinical Trials Communications","work_id":"f4fcf05b-1299-4ed6-9c86-e01a5bf0ac3c","year":2022},"citing_paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials","version":1},"reference_index":44,"source":"arxiv_source","source_observed_at":"2026-05-08T17:20:32.422258Z"},"links":{"citing_paper":"/paper/2605.04212"},"observation_digest":"sha256:b504acc9ee2462dc524ad4b65843308e9ff68d358fa7d052682f8a6d96e79113","observation_id":"693b317a-7823-47cd-b0c5-254d2ac5d347","resolution":{"observed_at":"2026-05-08T17:23:40.915618Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-06T06:34:29.942622+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2605.04212","last_updated":"2026-05-05T18:53:18Z","latest_version":1,"primary_category":"stat.ME","snapshot_observed_at":"2026-07-06T23:16:59.568304Z","submitted_at":"2026-05-05T18:53:18Z","title":"BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials"},"reference_resolution":{"displayed":44,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":1,"verified_exact":3,"verified_fuzzy":40},"total_outbound_references":44},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-06T06:34:29.942622+00:00","source":"crossref"},{"observed_at":"2026-08-06T06:34:23.284952+00:00","source":"retraction_watch"}],"thesis":"As of 6 August 2026, this Paper Citation Record lists 44 of 44 outbound references and 0 inbound Pith citation observations for arXiv:2605.04212."}